1 enrolling by invitation. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Enrolling by invitation 1 |
Follow Alks 3831: new trials by email Literature Review of Alks 3831 trials Research Report on Alks 3831
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Long-term Safety Extension Study of OLZ/SAM in Pediatric Subjects OLZ/SAM - Bipolar I Disorder, Schizophrenia | Phase 3 | Enrolling by invitation | Alkermes, Inc. | 236 | 2021-10-22 | 2026-08-14 |
Schizophrenia (1)
Alkermes, Inc. (1)
Argentina (1) · Brazil (1) · Colombia (1) · Mexico (1) · United States (1)